Abstract
Fibromyalgia is a common chronic pain condition of unknown aetiology, although mitochondrial dysfunction, oxidative stress, and inflammation have been implicated in the pathophysiology of this disorder. Treatment generally involves physiotherapy, anticonvulsants, and antidepressant therapy; however, the symptomatic relief conferred by these treatments can be very variable, and there is a need for additional therapeutic strategies. One such treatment which is gaining a lot of interest is the use of coenzyme Q10 (CoQ10) supplementation. The therapeutic efficacy associated with CoQ10 supplementation is thought to arise from the ability of supplementation to restore an underlying deficit in CoQ10 status which has been associated with fibromyalgia together with the ability of CoQ10 to improve mitochondrial activity, restore cellular antioxidant capacity, and ameliorate inflammation. This chapter outlines the evidence supporting the therapeutic utility of CoQ10 in the treatment of fibromyalgia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Guymer E, Littlejohn G (2013) Fibromyalgia. Aust Fam Physician 42(10):690–694
Romano GF, Tomassi S, Russell A, Mondelli V, Pariante CM (2015) Fibromyalgia and chronic fatigue: the underlying biology and related theoretical issues. Adv Psychosom Med 34:61–77
Cordero MD, de Miguel M, Carmona-López I, Bonal P, Campa F, Moreno-Fernández AM (2010) Oxidative stress and mitochondrial dysfunction in fibromyalgia. Neuro Endocrinol Lett 31(2):169–173
Cordero MD, Alcocer-Gómez E, Culic O, Carrión AM, de Miguel M, Díaz-Parrado E et al (2014) NLRP3 inflammasome is activated in fibromyalgia: the effect of CoQ10. Antioxd Redox Signal 20(8):1169–1180
Cordero MD, Cano-García FJ, Alcocer-Gómez E, De Miguel M, Sánchez-Alcázar JA (2012) Oxidative stress correlates with headache symptoms in fibromyalgia: CoQ10 effect on clinical improvement. PLoS One 7(4):e35677. https://doi.org/10.1371/journal.pone.0035677
Cordero MD, Alcocer-Gómez E, de Miguel M, Culic O, Carrión AM, Alvarez-Suarez JM et al (2013) Can CoQ10 improve clinical and molecular parameters in fibromyalgia? Antioxd Redox Signal 19(12):1356–1361
Cordero MD, Díaz-Parrado E, Carrión AM, Alfonsi S, Sánchez-Alcazar JA, Bullón P et al (2013) Is inflammation a mitochondrial dysfunction dependent event in fibromyalgia? Antioxid Redox Signal 18(7):800–807
Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH (2001) Cytokines play an aetiopathogenetic role in fibromyalgia: a hyphothesis and pilot study. Rheumatology (Oxford) 40(7):743–749
Castro-Marrero J, Cordero MD, Sáez-Francas N, Jimenez-Gutierrez C, Aguilar-Montilla FJ, Aliste L et al (2013) Could mitochondrial dysfunction be a differentiating marker between CFS and fibromyalgia? Antioxid Redox Signal 19(15):1855–1860
Cordero MD, Alcocer-Gómez E, Cano-García FJ, De Miguel M, Carrión AM, Navas P et al (2011) Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma. PLoS One 6(10):e26915. https://doi.org/10.1371/journal.pone.0026915
Duberley KE, Abramov AY, Chalasani A, Heales SJ, Rahman S, Hargreaves IP (2013) Human neuronal coenzyme Q10 deficiency results in global loss of mitochondrial respiratory chain activity, increased mitochondrial oxidative stress and reversal of ATP synthase activity: implications for pathogenesis and treatment. J Inherit Metab Dis 36(1):63–73
Cordero MD, De Miguel M, Moreno Fernández AM, Carmona López IM, Garrido Maraver J, Cotán D et al (2010) Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease. Arthritis Res Ther 12(1):R17. https://doi.org/10.1186/ar2918
Hargreaves IP (2003) Ubiquinone: cholesterol’s reclusive cousin. Ann Clin Biochem 40.(Pt 3:207–218
Zhen YU, Zhang HU (2019) NLRP3 inflammasome and inflammatory bowel disease. Front Immunol 10:276. https://doi.org/10.3389/fimmu.2019.00276
Yunus MB, Holt GS, Masi AT, Aldag JC (1988) Fibromyalgia syndrome among the elderly. Comparison with younger patients. J Am Geriatric Soc 36(11):987–995
Jacobson SA, Simpson RG, Lubahn C, Hu C, Belden CM, Davis KJ et al (2015) Characterization of fibromyalgia symptoms in patients 55 to 95 years old: a longitudinal study showing symptom persistence with suboptimal treatment. Aging Clin Exp Res 27(1):75–82
Busch AJ, Webber SC, Brachaniec M, Bidonde J, Bello-Haas VD, Danyliw AD et al (2011) Exercise therapy for fibromyalgia. Curr Pain Headache Rep 15(5):358–367
Bjorklund G, Dadar M, Chirumbolo S, Aaseth J (2018) Fibromyaslgia and nutrition: therapeutic possibilities? Biomed Pharmacother 103:531–538
Mohabbat AB, Mahapatra S, Jenkins SM, Bauer BA, Vincent A, Wahner-Roedler DL (2019) Use of complementary and integrative therapies by fibromyalgia patients: a 14-year follow-up study. Mayo Clin Proc Innov Qual Outcomes 3(4):418–428
Kalén A, Appelkvist EL, Dallner G (1989) Age-related changes in the lipid compositions of rat and human tissues. Lipids 24(7):579–584
Borg S, Verlaan S, Hemsworth J, Mijnarends DM, Schols JM, Luiking YC et al (2015) Micronutient intakes and potential inadequacies of community dwelling older adults: a systematic review. Br J Nutr 113(8):1195–1206
Hargreaves IP, Mantle D (2019) Supplementation with selenium and coenzyme Q10 in critically ill patients. Brit J Hosp Med 80(10):589–593
Eisinger J, Plantamura A, Marie PA, Ayavou T (1994) Selenium and magnesium status in fibromyalgia. Magnes Res 7(3–4):285–288
Mantle D (2015) Coenzyme Q10 and cardiovascular disease: an overview. Br J Cardiol 22(4):1–7
Crane FL (2001) Biochemical functions of coenzyme Q10. J Am Coll Nutr 20(6):591–598
Xia L, Nordman T, Olsson JM, Damdimopoulos A, Björkhem-Bergman L, Nalvarte I et al (2003) The mammalian selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defence against oxidative stress. J Biol Chem 278(4):2141–2146
Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, Döring F (2008) Functions of coenzyme Q10 in inflammation and gene expression. Biofactors 32(1–4):179–183
Miyamae T, Seki M, Naga T, Uchino S, Asazuma H, Yoshida T et al (2013) Increased oxidative stress and CoQ10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation. Redox Rep 18(1):12–19
Groven N, Fors EA, Reitan SK (2019) Patients with fibromyalgia and chronic fatigue syndrome show increased hsCRP compared to healthy controls. Brain Behav Immun 81:172–177
Sluka KA, Clauw DJ (2016) Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience 338:114–129
Alcocer-Gomez E, Sánchez-Alcázar JA, Cordero MD (2014) CoQ10 regulates serotonin levels and depressive symptoms in fibromyalgia symptoms. J Clin Psychopharmacol 34(2):277–278
Alcozer-Gomez E, Culic O, Navarro-Pando JM, Sánchez-Alcázar JA, Bullón P (2017) Effect of CoQ10 on psychopathological symptoms in fibromyalgia patients. CNS Neurosci Ther 23(2):188–189
Gurer G, Sendur OF, Ay C (2006) Serum lipid profile in fibromyalgia women. Clin Rheumatol 25(3):300–303
Codero MD, Alcocer-Gómez E, Cano-García FJ, Sánchez-Domínguez B, Fernández-Riejo P, Moreno Fernández AM et al (2014) Clinical symptoms in fibromyalgia are associated to overweight and lipid profile. Rheumatol Int 34(3):19–22
Acosta-Manzano P, Segura-Jiménez V, Estévez-López F, Álvarez-Gallardo IC, Soriano-Maldonado A, Borges-Cosic M et al (2017) Do women with fibromyalgia present higher cardiovascular risk profile than healthy women? Clin Exp Rheumatol 105(3):61–67
Hargreaves IP, Duncan AJ, Heales SJ, Land JM (2005) The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications. Drug Saf 28(8):659–676
Schmelzer C, Niklowitz P, Okun JG, Haas D, Menke T, Döring F (2011) Ubiquinol-induced gene expression signatures are translated into altered parameters of erythropoiesis and reduced low density lipoprotein cholesterol levels in humans. IUBMB Life 63(1):42–48
Mohseni M, Vafa MR, Hajimiresmail SJ, Zarrati M, Rahimi Forushani A, Bitarafan V et al (2014) Effects of coenzyme q10 supplementation on serum lipoproteins, plasma fibrinogen, and blood pressure in patients with hyperlipidemia and myocardial infarction. Iran Red Crescent Med J 16(10):e16433. https://doi.org/10.5812/ircmj.16433
Sawaddiruk P, Apaijai N, Paiboonworachat S, Kaewchur T, Kasitanon N, Jaiwongkam T et al (2019) Coenzyme Q10 supplementation alleviates pain in pregabalin-treated fibromyalgia patients via reducing brain activity and mitochondrial dysfunction. Free Radic Res 53(8):901–909
Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K (2008) Safety assessment of CoQ10. Biofactors 32(1–4):199–208
Engelsen J, Nielsen JD, Hansen KF (2003) Effect of CoQ10 and Ginkgo biloba on warfarin dosage in patients on long term warfarin treatment. A double blind placebo controlled cross-over trial. Ugeaskr Laeger 165(18):1868–1871
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hargreaves, I.P., Mantle, D. (2021). Targeted Treatment of Age-Related Fibromyalgia with Supplemental Coenzyme Q10. In: Guest, P.C. (eds) Reviews on New Drug Targets in Age-Related Disorders. Advances in Experimental Medicine and Biology(), vol 1286. Springer, Cham. https://doi.org/10.1007/978-3-030-55035-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-55035-6_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-55034-9
Online ISBN: 978-3-030-55035-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)